Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Grail Inc.

Integrating Emerging Science and Earlier Detection Practices to Play Our Part in Controlling Cancer

Release Date: May 18, 2021
Expiration Date:  May 18, 2022

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in early cancer detection. Primary care providers (PCPs), not oncologists, are usually the first point of contact for a patient at risk for cancer or needing an evaluation for cancer. Typically, in the United States, cancer screenings begin in primary care offices. The development of blood-based cancer tests—analysis of blood obtained in a noninvasive or minimally invasive manner for biomarkers of malignancy—offers the potential for a new era of earlier cancer detection. As trials generate data on the effectiveness of these tests, PCPs require education on how they work, how to encourage patients to utilize them, how to communicate results to patients, and how to fit testing into multidisciplinary patient care pathways within their workflow. PCPs play a key role on the front line of early cancer detection. However, they face many barriers that reduce their effectiveness in identifying cancer in its early stages. In addition, enduring inequality in patient access to screening results in worse prognoses and outcomes for vulnerable patient populations.
This panel discussion brings together experts in the development of these screening tests to discuss their implications for PCPs and their patients.
 
This educational activity is an archive of a live virtual symposium held on April 30, 2021.
 

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Grail Inc.

 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward internists and internal medicine subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in screening patients for cancer will be also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to

  • Outline current evidence-based guidelines in cancer screening for early detection
  • Review current evidence on biomarkers targeted by blood-based tests for cancer detection
  • Evaluate the sensitivity and specificity of blood-based tests for cancer detection
  • Utilize patient-centered approaches to integrate blood-based testing in screening and diagnosis of patients with cancer

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.

Faculty

Paul P. Doghramji, MD, FAAFP
Paul P. Doghramji, MD, FAAFP
Senior Attending Physician, Collegeville Family Practice
Medical Director, Health Services, Ursinus College
Collegeville, PA
Cofounder, Brookside Family Practice and Pediatrics
Pottstown, PA

Disclosures:Speakers Bureau: Allergan, Eisai, Harmony Biosciences, Novo Nordisk; Shareholder: CVS, Pfizer

Tomasz M. Beer, MD
Tomasz M. Beer, MD
Grover C. Bagby Endowed Chair for Prostate Cancer Research
Deputy Director, OHSU Knight Cancer Institute
Chief Medical Officer, CEDAR
Professor of Medicine, Hematology & Medical Oncology
Director, Prostate Cancer Research Program
Portland, OR
 
Disclosures:Grant Research Support: Alliance Foundation Trials, Astellas Pharma, Bayer Healthcare, Boehringer Ingelheim, Corcept Therapeutics, Endocyte, Freenome, Grail, Harpoon Therapeutics, Janssen Research & Development, Medivation, Sotio, Theraclone Sciences/OncoResponse, Zenith Epigenetics; Consultant: Arvinas, Astellas Pharma, AstraZeneca, Bayer Healthcare, Bristol Myers Squibb, Clovis Oncology, Constellation Pharmaceuticals, Grail, Janssen Pharmaceuticals, Myovant Sciences, Novartis Pharmaceuticals, Pfizer, Sanofi, Tolero Pharmaceuticals; Shareholder: Arvinas, Salarius Pharmaceuticals

Shannon L. Stott, PhD
Shannon L. Stott, PhD
Assistant Professor, Department of Medicine
Massachusetts General Hospital/Harvard Medical School
The MGH Cancer Center/BioMEMS Resource Center
Boston, MA

Disclosures:Grant Research Support: American Cancer Society, National Institutes of Health, V Foundation for Cancer Research, Swim Across America (all nonprofits); Consultant: External advisory committee member: Kansas Institute for Precision Medicine; Advisory role: Innovation Center, Merck KGaA; Shareholder: Spouse has stock options: Sigilon Therapeutics, Bioventus; Other: Patents issued and pending for some technology shared, no income received.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By